EP0641384A1 - INDUZIERBARE CYTOTOXISCHE mRNAs ENTHALTENE VIRUS RESISTENTE PFLANZEN - Google Patents

INDUZIERBARE CYTOTOXISCHE mRNAs ENTHALTENE VIRUS RESISTENTE PFLANZEN

Info

Publication number
EP0641384A1
EP0641384A1 EP93911073A EP93911073A EP0641384A1 EP 0641384 A1 EP0641384 A1 EP 0641384A1 EP 93911073 A EP93911073 A EP 93911073A EP 93911073 A EP93911073 A EP 93911073A EP 0641384 A1 EP0641384 A1 EP 0641384A1
Authority
EP
European Patent Office
Prior art keywords
rna
region
responsive rna
responsive
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93911073A
Other languages
English (en)
French (fr)
Other versions
EP0641384A4 (de
Inventor
Brent V. Edington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirna Therapeutics Inc
Original Assignee
Ribozyme Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribozyme Pharmaceuticals Inc filed Critical Ribozyme Pharmaceuticals Inc
Publication of EP0641384A1 publication Critical patent/EP0641384A1/de
Publication of EP0641384A4 publication Critical patent/EP0641384A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • C12N2310/111Antisense spanning the whole gene, or a large part of it
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/12Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/124Type of nucleic acid catalytic nucleic acids, e.g. ribozymes based on group I or II introns
    • C12N2310/1241Tetrahymena
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/12Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/127DNAzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/3212'-O-R Modification

Definitions

  • the substrate region is part of an exon or a leader region or overlaps the junction between the two (which includes the ribosome recognition sequence, and the initiation codon) , or includes a region necessary for the self-splicing reaction.
  • Fig. 4 is a copy of a photograph of a polyacrylamide gel showing the results of in vitro transcription reactions carried out in the presence of [ ⁇ 32 P]CTP using the parent plasmid (pTETBLU) and the three splicing mutants (pTET14, pTET1419, pTET21-24) as templates.
  • Each set of three lanes represents the transcription products before (0) and after (15 or 60 min) the change to splicing conditions.
  • the template used is given above each set of lanes, and the restriction enzyme used to linearize the template is shown at the top.
  • FL denotes the full-length precursor RNA and LE indicates ligated exons.
  • the regulatory domain may also include a region that will disfavor hybridization of non-specific nucleic acids .i.e.. nucleic acids other than the signal nucleic acid) to the region immediately adjacent to the inhibitor domain.
  • This region is referred to as an inverted repeat and can fold to form a hairpin structure.
  • the detailed nature of the inhibitor region, the substrate region, and the anti-inhibitor region will depend, in part, on the extent that translation is to be regulated. The more stable the intramolecular base-paired domain formed by hybridization of the inhibitor region to the substrate region, the more translation will be inhibited.
  • Intramolecular base pair formation between the inhibitor region and the substrate region prevents hybridization of the 5'-splice junction to the internal guide sequence, and splicing is prevented.
  • This responsive RNA molecule is designed so that the inhibitor region is also complementary to the anti-inhibitor region of the signal nucleic acid.
  • the inhibitor region hybridizes to the anti-inhibitor region freeing the 5'-splice junction for participation in the self-splicing reaction.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP93911073A 1992-05-14 1993-05-06 INDUZIERBARE CYTOTOXISCHE mRNAs ENTHALTENE VIRUS RESISTENTE PFLANZEN. Withdrawn EP0641384A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88310792A 1992-05-14 1992-05-14
US883107 1992-05-14
PCT/US1993/004240 WO1993023532A1 (en) 1992-05-14 1993-05-06 VIRUS RESISTANT PLANTS CONTAINING INDUCIBLE CYTOTOXIC mRNAs

Publications (2)

Publication Number Publication Date
EP0641384A1 true EP0641384A1 (de) 1995-03-08
EP0641384A4 EP0641384A4 (de) 1995-07-12

Family

ID=25382000

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93911073A Withdrawn EP0641384A4 (de) 1992-05-14 1993-05-06 INDUZIERBARE CYTOTOXISCHE mRNAs ENTHALTENE VIRUS RESISTENTE PFLANZEN.

Country Status (6)

Country Link
EP (1) EP0641384A4 (de)
JP (1) JPH07507931A (de)
AU (1) AU4234293A (de)
CA (1) CA2135643A1 (de)
MX (1) MX9302804A (de)
WO (1) WO1993023532A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10500010A (ja) * 1994-05-11 1998-01-06 ジョン インズ センター イノベイションズ リミティド 植物において病原体耐性を誘導する方法
US5712096A (en) * 1994-08-23 1998-01-27 University Of Massachusetts Medical Center Oligoribonucleotide assays for novel antibiotics
US6235974B1 (en) 1996-12-05 2001-05-22 Cornell Research Foundation, Inc. Hypersensitive response induced resistance in plants by seed treatment with a hypersensitive response elicitor
US6998515B1 (en) 1997-01-27 2006-02-14 Cornell Research Foundation, Inc. Use of a nucleic acid encoding a hypersensitive response elicitor polypeptide to enhance growth in plants
US6277814B1 (en) 1997-01-27 2001-08-21 Cornell Research Foundation, Inc. Enhancement of growth in plants
BR9809699A (pt) 1997-05-30 2000-07-11 Cornell Res Foundation Inc Fragmento isolado de uma proteìna ou polipeptìdeo eliciador de resposta hipersensìvel de erwinia, molécula de dna isolada, sistema de expressão, célula hospedeira, planta transgênica, semente de planta transgênica, e, processos para conferir resistência a doença e intensificar crescimento de plantas e para controlar insetos para plantas
US6262018B1 (en) 1997-08-06 2001-07-17 Cornell Research Foundation, Inc. Hypersensitive response elicitor from Erwinia amylovora and its use
US6228644B1 (en) 1997-08-06 2001-05-08 Cornell Research Foundation, Inc. Hypersensitive response elicitor from Erwinia amylovora, its use, and encoding gene
US6172184B1 (en) 1997-08-06 2001-01-09 Cornell Research Foundation, Inc. Hypersensitive response elicitor from Pseudomonas syringae and its use
US6960705B2 (en) 1998-10-05 2005-11-01 Eden Bioscience Corporation Nucleic acid encoding a hypersensitive response elicitor from Xanthomonas campestris
US6858707B1 (en) 1998-10-05 2005-02-22 Eden Bioscience Corporation Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response
US6624139B1 (en) 1998-11-05 2003-09-23 Eden Bioscience Corporation Hypersensitive response elicitor-induced stress resistance

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601680D0 (en) * 1986-01-23 1986-02-26 Agricultural Genetics Co Modification of plant viruses
ES2165345T3 (es) * 1987-07-10 2002-03-16 Syngenta Participations Ag Resistencia virica inducible en plantas.
ZA885916B (en) * 1987-09-15 1989-04-26 Gen Hospital Corp Pathogenesis-related proteins in plants
CN1033645A (zh) * 1988-10-22 1989-07-05 中国科学院上海植物生理研究所 控制植物病毒病的基因工程方法
NL9001711A (nl) * 1989-10-03 1991-05-01 Clovis Matton N V Genetische manipulaties met recombinant dna, dat van rna virus afgeleide sequenties omvat.
WO1991013994A1 (en) * 1990-03-13 1991-09-19 Commonwealth Scientific And Industrial Research Organisation Gene expression
EP0479180A3 (en) * 1990-10-05 1992-08-26 Hoechst Aktiengesellschaft Virus resistant plants, method for their production
NZ314629A (en) * 1991-01-17 2000-08-25 Gen Hospital Corp Use trans-splicing ribozymes to prepare medicaments for gene therapies
NZ241311A (en) * 1991-01-17 1995-03-28 Gen Hospital Corp Rna sequence having trans-splicing activity, plant strains
EP0568641A4 (en) * 1991-01-25 1994-09-14 Us Biochemical Corp Regulation of nucleic acid translation

Also Published As

Publication number Publication date
EP0641384A4 (de) 1995-07-12
AU4234293A (en) 1993-12-13
JPH07507931A (ja) 1995-09-07
CA2135643A1 (en) 1993-11-25
WO1993023532A1 (en) 1993-11-25
MX9302804A (es) 1994-04-29

Similar Documents

Publication Publication Date Title
KR100235792B1 (ko) 트랜스-스플라이싱 리보자임
JP4321877B2 (ja) トランス―スプライスにより生成される治療用分子
US5741679A (en) Regulatable nucleic acid therapeutic and methods of use thereof
Heidenreich et al. Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1.
US5916808A (en) Antisense oligonucleotides which combat aberrant splicing and methods of using the same
US6852535B1 (en) Polymerase III-based expression of therapeutic RNAS
CN107208096B (zh) 基于crispr的组合物和使用方法
US9012140B2 (en) Target-dependent nucleic acid adapter
CN104520429B (zh) 通过Cas9-crRNA复合物的RNA指导的DNA裂解
Köhler et al. Trans-splicing ribozymes for targeted gene delivery
US5872241A (en) Multiple component RNA catalysts and uses thereof
WO1995015394A1 (en) Targeted rna degradation using nuclear antisense rna
WO1993023532A1 (en) VIRUS RESISTANT PLANTS CONTAINING INDUCIBLE CYTOTOXIC mRNAs
AU1341092A (en) Regulation of nucleic acid translation
EP0558490A1 (de) Tragbare ribozyme-kassetten, diese kodierende dna-sequenzen, dadurch kodierte ribozyme und diese enthaltende mitteln
US5942395A (en) Hybrid ribozymes and methods of use
Nivinskas et al. Post-transcriptional control of bacteriophage T4 gene 25 expression: mRNA secondary structure that enhances translational initiation
Arraiano et al. Identification of endonucleolytic cleavage sites involved in decay of Escherichia coli trxA mRNA
AU2006317222B2 (en) DNA constructs for specific inhibition of gene expression by RNA interference
US6130092A (en) Ribozyme gene library and method for making
US20110171727A1 (en) Compositions and methods for activating genes of interest
US5739310A (en) Ribosomes as vectors for RNA
US5695992A (en) Expression cassette for antisense expression of ribozyme
CN121399265A (zh) 环形rna及其制备方法
AU2007249158A1 (en) Production of ssDNA in vivo

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19941118

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RHK1 Main classification (correction)

Ipc: C12N 15/82

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19960802